JAK3 and primary cutaneous T-cell non-Hodgkin lymphoma: Subsequent experiments in a mouse Jak3 A572V knock-in line have demonstrated that partial trisomy 21 enhanced the aggressiveness of cutaneous T-cell lymphoma (CTCL)-like phenotypes, making it a fully penetrant, lethal disease [17].